Medication adherence and its determinants in patients with schizophrenia: A cross-sectional observational study.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i6.2000Keywords:
Schizophrenia, Medication Adherence, Medication Adherence Rating Scale, Insight, Substance Use, Family Support, Predictors, Non-compliance, Mental Health, PsychopharmacologyAbstract
Background: Medication adherence is critical for optimal clinical outcomes in schizophrenia. Non-adherence contributes to symptom relapse, increased hospitalizations, and poor functional recovery. Identifying the factors associated with adherence may guide targeted interventions.
Objectives: To assess the level of medication adherence among patients with schizophrenia and to identify sociodemographic and clinical factors associated with poor adherence.
Methods: This cross-sectional observational study was conducted on 100 patients diagnosed with schizophrenia attending the psychiatry outpatient department of a tertiary care hospital. Medication adherence was measured using the Medication Adherence Rating Scale (MARS). Sociodemographic data, clinical history, and relevant correlates such as insight, substance use, and family support were recorded. Statistical analyses included chi-square tests, t-tests.
Results: Among the 100 patients, 37% exhibited high adherence, 26% showed moderate adherence, and 37% had low adherence, with a mean MARS score of 5.6 ± 2.3. Poor adherence was more frequent among unemployed and less-educated individuals, whereas no significant associations were noted with age or marital status. Clinically, poor adherence was significantly linked to longer illness duration (p = 0.002), poor insight (p < 0.001), absence of family support (p = 0.001), and concurrent substance use (p = 0.003). Multivariate analysis further confirmed poor insight (AOR = 5.61, p < 0.001), illness duration beyond five years (AOR = 2.84, p = 0.015), substance abuse (AOR = 2.91, p = 0.023), and lack of family support (AOR = 3.42, p = 0.025) as independent predictors of poor adherence.
Conclusions: The findings highlight a high burden of non-adherence in schizophrenia, predominantly influenced by modifiable psychosocial and clinical factors. Interventions must be tailored to improve insight, support systems, and address substance use.
Recommendations: Early psychoeducation, active caregiver engagement, and dual diagnosis interventions are essential strategies to enhance adherence and prevent relapse among patients with chronic schizophrenia.
References
Yu W, Tong J, Sun X, Chen F, Zhang J, Pei Y, Zhang T, Zhang J, Zhu B. Analysis of Medication Adherence and Its Influencing Factors in Patients with Schizophrenia in the Chinese Institutional Environment. Int J Environ Res Public Health. 2021 Apr 29;18(9):4746. doi: 10.3390/ijerph18094746. PMID: 33946836; PMCID: PMC8125059. https://doi.org/10.3390/ijerph18094746
Higashi K, Medic G, Littlewood KJ, Diez T, Granström O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013 Aug;3(4):200-18. doi: 10.1177/2045125312474019. PMID: 24167693; PMCID: PMC3805432. https://doi.org/10.1177/2045125312474019
Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PLoS One. 2015 Mar 27;10(3):e0120560. doi: 10.1371/journal.pone.0120560. PMID: 25816353; PMCID: PMC4376899. https://doi.org/10.1371/journal.pone.0120560
Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatry. 2012 Oct 22;2(5):74-82. doi: 10.5498/wjp.v2.i5.74. PMID: 24175171; PMCID: PMC3782179. https://doi.org/10.5498/wjp.v2.i5.74
Ramdour S, Duxbury JA, Becket G, Wilson S. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication. J Psychiatr Ment Health Nurs. 2015 Sep;22(7):491-501. doi: 10.1111/jpm 12210. Epub 2015 May 20. PMID: 25990303. https://doi.org/10.1111/jpm.12210
Bressington D, Mui J, Gray R. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross-sectional study. Int J Ment Health Nurs. 2013 Feb;22(1):35-46. doi: 10.1111/j.1447-0349.2012.00830.x. Epub 2012 Jun 27. PMID: 22738372. https://doi.org/10.1111/j.1447-0349.2012.00830.x
Ali MM, Taha MM, Ahmed AE, Ali S, Baiti MA, Alhazmi AA, Alfaifi BA, Majrabi RQ, Khormi NQ, Hakami AA, Alqaari RA, Alhasani RA, Abdelwahab SI. Psychotropic Medication Adherence and Its Associated Factors Among Schizophrenia Patients: Exploring the Consistency of Adherence Scales. Cureus. 2023 Sep 28;15(9):e46118. doi: 10.7759/cureus 46118. PMID: 37900367; PMCID: PMC10612138. https://doi.org/10.7759/cureus.46118
Yao L, Liu H, Tian X. Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study. Psychiatry Res. 2022 Nov;317:114841. Doi: 10.1016/j.psychres.2022.114841. Epub 2022 Sep 9. PMID: 36113253; PMCID: PMC9461236. https://doi.org/10.1016/j.psychres.2022.114841
Endriyani L, Chien CH, Huang XY, Chieh-Yu L. The influence of adherence to antipsychotic medication on the quality of life among patients with schizophrenia in Indonesia. Perspect Psychiatr Care. 2019 Apr;55(2):147-152. doi: 10.1111/ppc.12276. Epub 2018 Mar 26. PMID: 29578605. https://doi.org/10.1111/ppc.12276
Tamene FB, Mihiretie EA, Mulugeta A, Kassaye A, Gubae K, Wondm SA. Medication non-adherence and associated factors among people with schizophrenia: multicenter cross-sectional study in Northwest Ethiopia. BMC Psychiatry. 2024 Aug 19;24(1):567. doi: 10.1186/s12888-024-06004-7. PMID: 39160469; PMCID: PMC11334456. https://doi.org/10.1186/s12888-024-06004-7
Li X, Xiao S, Sun Y, Zheng Y, Huang J, Wei N, Mao C, Zhang S, Teng Y. Medication adherence and needs among patients with schizophrenia in China: a qualitative study. BMJ Open. 2025 Jan 25;15(1):e092073. doi: 10.1136/bmjopen-2024-092073. PMID: 39863410; PMCID: PMC11784175. https://doi.org/10.1136/bmjopen-2024-092073
Chaudhari B, Saldanha D, Kadiani A, Shahani R. Evaluation of treatment adherence in outpatients with schizophrenia. Ind Psychiatry J. 2017 Jul-Dec;26(2):215-222. doi: 10.4103/ipj.ipj_24_17. PMID: 30089972; PMCID: PMC6058450. https://doi.org/10.4103/ipj.ipj_24_17
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sai Krishna Sakhamudi , Dr. Prashanth Challuri

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.